Drugs & TargetsFree Tagrisso receives FDA approval as adjuvant therapy for NSCLC with EGFR mutations January 08, 2021Vol.47 No.01
Drugs & TargetsFree Iclusig receives FDA sNDA approval for adult patients with resistant or intolerant chronic-phase CML January 08, 2021Vol.47 No.01
Drugs & TargetsFree Xpovio receives FDA approval for refractory or relapsed multiple myeloma January 08, 2021Vol.47 No.01
Drugs & TargetsFree Orgovyx receives FDA approval for advanced prostate cancer January 08, 2021Vol.47 No.01
Drugs & TargetsFree Margenza receives FDA approval for metastatic HER2-positive breast cancer January 08, 2021Vol.47 No.01
Drugs & TargetsFree CPI-613 receives FDA Fast Track Designation for treatment of AML January 08, 2021Vol.47 No.01
Drugs & TargetsFree EU CHMP issues positive opinion for Keytruda as first-line treatment in adult patients in colorectal cancer indication January 08, 2021Vol.47 No.01
Drugs & TargetsFree Bayer and Veracyte collaborate on precision oncology in thyroid cancer January 08, 2021Vol.47 No.01
Drugs & TargetsFree Servier to acquire Agios Pharmaceuticals’ oncology business January 08, 2021Vol.47 No.01
